Thyrocare Technologies standalone net profit rises 14.14% in the March 2025 quarter
Net profit of Thyrocare Technologies rose 14.14% to Rs 21.95 crore in the quarter ended March 2025 as against Rs 19.23 crore during the previous quarter ended March 2024. Sales rose 23.11% to Rs 173.87 crore in the quarter ended March 2025 as against Rs 141.23 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.64% to Rs 95.78 crore in the year ended March 2025 as against Rs 71.14 crore during the previous year ended March 2024. Sales rose 20.82% to Rs 633.10 crore in the year ended March 2025 as against Rs 524.02 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 173.87 | 141.23 | 23 | 633.10 | 524.02 | 21 |
| OPM % | 32.00 | 23.78 | - | 29.54 | 25.55 | - |
| PBDT | 59.58 | 35.46 | 68 | 197.73 | 137.33 | 44 |
| PBT | 47.80 | 25.05 | 91 | 151.21 | 98.22 | 54 |
| NP | 21.95 | 19.23 | 14 | 95.78 | 71.14 | 35 |
